Correction to: Omeprazole and Risk of Hypertension: Analysis of Existing Literature and the WHO Global Pharmacovigilance Database
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Correction to: Omeprazole and Risk of Hypertension: Analysis of Existing Literature and the WHO Global Pharmacovigilance Database ; day:24 ; month:8 ; year:2024 ; pages:1
Drugs - real world outcomes ; (24.8.2024), 1
- Klassifikation
-
Soziale Probleme, Sozialdienste, Versicherungen
- Urheber
-
Bahta, Merhawi
Russom, Natnael
Ghebrenegus, Amon Solomon
Okubamichael, Yohana Tecleab
Russom, Mulugeta
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40801-024-00448-9
- URN
-
urn:nbn:de:101:1-2411121019295.574059904705
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
04.04.2025, 07:27 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Bahta, Merhawi
- Russom, Natnael
- Ghebrenegus, Amon Solomon
- Okubamichael, Yohana Tecleab
- Russom, Mulugeta
- SpringerLink (Online service)
Ähnliche Objekte (12)
Omeprazole and Risk of Hypertension: Analysis of Existing Literature and the WHO Global Pharmacovigilance Database
Pharmacovigilance workflow in Europe and Italy and pharmacovigilance terminology
Immune Checkpoint Inhibitors and Scleroderma: Data from the European Pharmacovigilance Database
Antidepressants and movement disorders: a postmarketing study in the world pharmacovigilance database
Coadministration of tizanidine and ciprofloxacin: a retrospective analysis of the WHO pharmacovigilance database
Diclofenac and the Risk of Rhabdomyolysis: Analysis of Publications and the WHO Global Pharmacovigilance Database
PROGgeneV2: enhancements on the existing database
Drug-associated hyperammonaemia: a Bayesian analysis of the WHO Pharmacovigilance Database
Pharmacovigilance study of famciclovir in the Food and Drug administration adverse event reporting system database
Big data, medicines safety and pharmacovigilance
Local anesthetics systemic toxicity in children: analysis of the French pharmacovigilance database
Drug safety of rosiglitazone and pioglitazone in France: a study using the French PharmacoVigilance database
Omeprazole and Risk of Hypertension: Analysis of Existing Literature and the WHO Global Pharmacovigilance Database
Pharmacovigilance workflow in Europe and Italy and pharmacovigilance terminology
Immune Checkpoint Inhibitors and Scleroderma: Data from the European Pharmacovigilance Database
Antidepressants and movement disorders: a postmarketing study in the world pharmacovigilance database
Coadministration of tizanidine and ciprofloxacin: a retrospective analysis of the WHO pharmacovigilance database
Diclofenac and the Risk of Rhabdomyolysis: Analysis of Publications and the WHO Global Pharmacovigilance Database
PROGgeneV2: enhancements on the existing database
Drug-associated hyperammonaemia: a Bayesian analysis of the WHO Pharmacovigilance Database
Pharmacovigilance study of famciclovir in the Food and Drug administration adverse event reporting system database
Big data, medicines safety and pharmacovigilance
Local anesthetics systemic toxicity in children: analysis of the French pharmacovigilance database
Drug safety of rosiglitazone and pioglitazone in France: a study using the French PharmacoVigilance database
Omeprazole and Risk of Hypertension: Analysis of Existing Literature and the WHO Global Pharmacovigilance Database
Pharmacovigilance workflow in Europe and Italy and pharmacovigilance terminology
Immune Checkpoint Inhibitors and Scleroderma: Data from the European Pharmacovigilance Database
Antidepressants and movement disorders: a postmarketing study in the world pharmacovigilance database
Coadministration of tizanidine and ciprofloxacin: a retrospective analysis of the WHO pharmacovigilance database
Diclofenac and the Risk of Rhabdomyolysis: Analysis of Publications and the WHO Global Pharmacovigilance Database
PROGgeneV2: enhancements on the existing database
Drug-associated hyperammonaemia: a Bayesian analysis of the WHO Pharmacovigilance Database
Pharmacovigilance study of famciclovir in the Food and Drug administration adverse event reporting system database
Big data, medicines safety and pharmacovigilance
Local anesthetics systemic toxicity in children: analysis of the French pharmacovigilance database